86 related articles for article (PubMed ID: 2102703)
1. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in adult patients with hypersecretory bronchopulmonary diseases].
Campisi U; Sciutto L; Patti S
Boll Chim Farm; 1990; 129(10-11):56S-59S. PubMed ID: 2102703
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate administered by aerosol in adult patients with catarrhal pathology of otorhinolaryngologic origin].
Lomeo G
Boll Chim Farm; 1990; 129(10-11):53S-55S. PubMed ID: 2102702
[TBL] [Abstract][Full Text] [Related]
3. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in patients with exacerbated chronic bronchitis].
Scillieri E
Boll Chim Farm; 1990; 129(10-11):68S-74S. PubMed ID: 2102705
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in a double-blind crossover experiment on chronic obstructive bronchopneumopathy].
Iaia E
Boll Chim Farm; 1990; 129(10-11):60S-67S. PubMed ID: 2102704
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in combination with antibiotic and bronchoactive therapy in adult patients with acute and chronic bronchopneumopathy with prevalent exudative component].
Casali L
Boll Chim Farm; 1990; 129(10-11):49S-52S. PubMed ID: 2102701
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic bronchopulmonary diseases with a N-(2-amino-3,5-dibromobenzyl-N-methyl-N-cyclohexl-ammonium chloride and benzidamine chlorohydrate combination].
Gini R
Prensa Med Argent; 1971; 58(13):673-6. PubMed ID: 5566940
[No Abstract] [Full Text] [Related]
7. [A new contribution to the treatment of chronic bronchopneumopathies: letosteine].
Macquet V; Ficheroulle X; Ta Van P; Peltier M
Lille Med; 1979 Nov; 24(9):735-8. PubMed ID: 529981
[No Abstract] [Full Text] [Related]
8. [Effectiveness and tolerance of a new molecule with secreto-dynamic activity: nesosteine].
Gatto PG; Gramolini C; Valenti S
Clin Ter; 1989 Jan; 128(2):87-97. PubMed ID: 2523778
[TBL] [Abstract][Full Text] [Related]
9. [The control of bronchial secretions in chronic hypersecretory bronchopneumopathies: the role of letosteine].
Morandini G; Finiguerra M; Fraticelli G; Ferraris F; Gallone F
Clin Ter; 1986 Feb; 116(3):179-93. PubMed ID: 3516541
[No Abstract] [Full Text] [Related]
10. Clinical trial with CO-1177: a preliminary report.
Mbuyamba P
Int J Clin Pharmacol Res; 1986; 6(2):119-21. PubMed ID: 3522442
[TBL] [Abstract][Full Text] [Related]
11. Rheological profile of nesosteine: a new mucoactive agent.
Braga PC; Beghi G; Castelli C; Grasselli G; Ornaghi A; Rampoldi C; Zheng Y; Allegra L
Int J Clin Pharmacol Res; 1989; 9(1):77-83. PubMed ID: 2707929
[TBL] [Abstract][Full Text] [Related]
12. [Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies].
Baracco F; Repetto E; Giordano L
Minerva Med; 1969 Sep; 60(75):3509-13. PubMed ID: 5344811
[No Abstract] [Full Text] [Related]
13. No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases.
Medici TC; Shang H; Grosgurin P; Berg P; Achermann R; Wehrli R
Bull Eur Physiopathol Respir; 1985; 21(6):477-83. PubMed ID: 3907738
[TBL] [Abstract][Full Text] [Related]
14. [Possibilities of the use in the tracheo-bronchial hypersecretion syndrome of a muco-fluidifying compound].
Alinei D; Alinei E
Ann Laringol Otol Rinol Faringol; 1976; 75(3-4):275-80. PubMed ID: 1037661
[No Abstract] [Full Text] [Related]
15. [Bronchopulmonary diseases in advanced age. Therapy using Expectorans Solucampher].
Boecker M
ZFA (Stuttgart); 1979 Feb; 55(6):400-2. PubMed ID: 419831
[No Abstract] [Full Text] [Related]
16. [Rheology of expectoration and control of mucolytic therapy by use of a thermostatic capillary viscometer].
Volker D
Bronchopneumologie; 1976; 26(3):238-46. PubMed ID: 1016883
[No Abstract] [Full Text] [Related]
17. Double-blind, placebo-controlled clinical evaluation of guaimesal in outpatients.
Jager EG
Clin Ther; 1989; 11(3):341-62. PubMed ID: 2663163
[TBL] [Abstract][Full Text] [Related]
18. [Metabolism of 4-carbomethoxythiazolidine chlorohydrate to cysteine through human expectorate and lung homogenates, and its action on glycoproteins of mucus].
Conte A; Ronca G
Boll Chim Farm; 1990; 129(10-11):45S-48S. PubMed ID: 2102700
[TBL] [Abstract][Full Text] [Related]
19. Oral neltenexine in patients with obstructive airways diseases: an open, randomised, controlled comparison versus sobrerol.
Fadda G
Minerva Med; 2001 Aug; 92(4):269-75. PubMed ID: 11535970
[TBL] [Abstract][Full Text] [Related]
20. [The respiro-phonogram for the analysis of the effect of a broncho-secretolytic agent].
Algan O; Kienle H
Med Monatsschr; 1966 Apr; 20(4):174-8. PubMed ID: 5966185
[No Abstract] [Full Text] [Related]
[Next] [New Search]
